Regional Citrate vs. Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy Among Critically Ill Patients with AKI: A Randomized Clinical Trial
20200 citationsJournal Article
Field-Weighted Citation Impact: 0.00
Regional Citrate vs. Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy Among Critically Ill Patients with AKI: A Randomized Clinical Trial | Researchclopedia